Vinayak Doraiswamy
CIK 1862458 · Chief Scientific Officer · last filed 2026-05-18
Vinayak Doraiswamy is a Chief Scientific Officer who has filed 17 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $140.7K of ATRC on May 18, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.65M
1
17
-$1.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATRC | Chief Scientific Officer | 91,875 | $28.79 | $2.65M | -$1.33M | 17 | 2026-05-18 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | ATRC | Sell (S) | −5,000 | -$140.7K | EDGAR |
| 2026-03-16 | ATRC | Sell (S) | −5,000 | -$149.2K | EDGAR |
| 2026-03-03 | ATRC | Mixed | +30,003 | -$487.2K | EDGAR |
| 2025-08-07 | ATRC | Sell (S) | −2,500 | -$91.5K | EDGAR |
| 2025-07-02 | ATRC | Grant (A) | +822 | $21.2K | EDGAR |
| 2025-05-30 | ATRC | Sell (S) | −2,500 | -$83.6K | EDGAR |
| 2025-03-04 | ATRC | Mixed | +16,266 | -$374.7K | EDGAR |
| 2024-07-02 | ATRC | Grant (A) | +707 | $13.7K | EDGAR |
| 2024-03-05 | ATRC | Mixed | +19,767 | -$321.3K | EDGAR |
| 2023-07-03 | ATRC | Grant (A) | +557 | $21.2K | EDGAR |